FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313706516> ?p ?o ?g. }

• W4313706516 abstract "Measuring the prevalence of doping in recreational sport is difficult. However, to fit their initiatives, National Anti-Doping Organizations are interested in knowing the numbers, so their scarce resources are not wasted. The present study aimed to estimate the prevalence of doping and over-the-counter medicine use for performance enhancement among recreational athletes in eight European countries.A survey covering + 200 sports aimed at recreational athletes 15 years and older was distributed via social media to sports clubs and individuals in eight European countries. To overcome social desirability bias, we applied indirect questioning by using the Randomized Response Technique and asked for the use of over-the-counter medicine and doping for the year 2019.The prevalence of the use of over-the-counter medications for performance enhancement was estimated at 10.4%. We differentiated between the concept of doping as the behavior to enhance performance in a certain sport and the concept of a doper as a property of a person. The prevalence of dopers in recreational sport was found to be 0.4%, with 3.1% male and 0% female dopers. Responses were separated into four categories: Artistic sports, Combat sports, Games, and CGS sports (i.e., sports measured in centimeters, grams, and seconds). The overall prevalence of doping in recreational sports was found to be 1.6%, and the results from Artistic and CGS sports did not differ significantly from this. However, in Games we found an estimated doping prevalence of 6.9%.The estimates for the prevalence of dopers and doping in this study do not equal Anti-Doping Rule Violations as stipulated by the World Anti-Doping Agency. Still, while doping is not absent in recreational sport in Europe, it appears to be a low frequent phenomenon. Also, the differences in doping prevalence between the sports categories might reflect structural and competition-related differences, rather than differences in the logic of the sporting competition or discipline-related subcultures.While few recreational athletes appear to use illegal drugs to enhance performance, those who do use them are more often men than women. Yet, 1 in 10 recreational athletes uses over-the-counter medication for performance enhancement and more than 4 out of 10 use medication for other reasons than performance enhancement when doing sports. The highest doping prevalence was found in the sub-category of Games, which can likely be attributed to competition-related differences between the categories. Therefore, research on doping in recreational sports needs tailored approaches to come to a better understanding of the phenomenon." @default.
• W4313706516 created "2023-01-08" @default.
• W4313706516 creator A5025961433 @default.
• W4313706516 creator A5053212232 @default.
• W4313706516 creator A5071274690 @default.
• W4313706516 creator A5076767301 @default.
• W4313706516 date "2023-01-08" @default.
• W4313706516 modified "2023-10-16" @default.
• W4313706516 title "Recreational Athletes’ Use of Performance-Enhancing Substances: Results from the First European Randomized Response Technique Survey" @default.
• W4313706516 cites W1966800785 @default.
• W4313706516 cites W1968094317 @default.
• W4313706516 cites W1980300074 @default.
• W4313706516 cites W1989240373 @default.
• W4313706516 cites W1997457562 @default.
• W4313706516 cites W2001277036 @default.
• W4313706516 cites W2013823004 @default.
• W4313706516 cites W2032732258 @default.
• W4313706516 cites W2037230020 @default.
• W4313706516 cites W2040419687 @default.
• W4313706516 cites W2041223402 @default.
• W4313706516 cites W2048788123 @default.
• W4313706516 cites W2054065788 @default.
• W4313706516 cites W2056172448 @default.
• W4313706516 cites W2063357448 @default.
• W4313706516 cites W2100729733 @default.
• W4313706516 cites W2108084851 @default.
• W4313706516 cites W2122345666 @default.
• W4313706516 cites W2138147903 @default.
• W4313706516 cites W2152304842 @default.
• W4313706516 cites W2155932121 @default.
• W4313706516 cites W2157767588 @default.
• W4313706516 cites W2405328327 @default.
• W4313706516 cites W2479900411 @default.
• W4313706516 cites W2540043301 @default.
• W4313706516 cites W2748004808 @default.
• W4313706516 cites W2783124988 @default.
• W4313706516 cites W2784645333 @default.
• W4313706516 cites W2790136216 @default.
• W4313706516 cites W2793941254 @default.
• W4313706516 cites W2905016813 @default.
• W4313706516 cites W2996976236 @default.
• W4313706516 cites W3024306997 @default.
• W4313706516 cites W3042775434 @default.
• W4313706516 cites W3102859770 @default.
• W4313706516 cites W3106889297 @default.
• W4313706516 cites W3111131207 @default.
• W4313706516 cites W3159756213 @default.
• W4313706516 cites W4230013642 @default.
• W4313706516 cites W4233538609 @default.
• W4313706516 doi "https://doi.org/10.1186/s40798-022-00548-2" @default.
• W4313706516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36617340" @default.
• W4313706516 hasPublicationYear "2023" @default.
• W4313706516 type Work @default.
• W4313706516 citedByCount "5" @default.
• W4313706516 countsByYear W43137065162023 @default.
• W4313706516 crossrefType "journal-article" @default.
• W4313706516 hasAuthorship W4313706516A5025961433 @default.
• W4313706516 hasAuthorship W4313706516A5053212232 @default.
• W4313706516 hasAuthorship W4313706516A5071274690 @default.
• W4313706516 hasAuthorship W4313706516A5076767301 @default.
• W4313706516 hasBestOaLocation W43137065161 @default.
• W4313706516 hasConcept C110269972 @default.
• W4313706516 hasConcept C15744967 @default.
• W4313706516 hasConcept C17744445 @default.
• W4313706516 hasConcept C1862650 @default.
• W4313706516 hasConcept C199539241 @default.
• W4313706516 hasConcept C2781054738 @default.
• W4313706516 hasConcept C2986800882 @default.
• W4313706516 hasConcept C43893838 @default.
• W4313706516 hasConcept C518677369 @default.
• W4313706516 hasConcept C71924100 @default.
• W4313706516 hasConcept C99454951 @default.
• W4313706516 hasConcept C99508421 @default.
• W4313706516 hasConceptScore W4313706516C110269972 @default.
• W4313706516 hasConceptScore W4313706516C15744967 @default.
• W4313706516 hasConceptScore W4313706516C17744445 @default.
• W4313706516 hasConceptScore W4313706516C1862650 @default.
• W4313706516 hasConceptScore W4313706516C199539241 @default.
• W4313706516 hasConceptScore W4313706516C2781054738 @default.
• W4313706516 hasConceptScore W4313706516C2986800882 @default.
• W4313706516 hasConceptScore W4313706516C43893838 @default.
• W4313706516 hasConceptScore W4313706516C518677369 @default.
• W4313706516 hasConceptScore W4313706516C71924100 @default.
• W4313706516 hasConceptScore W4313706516C99454951 @default.
• W4313706516 hasConceptScore W4313706516C99508421 @default.
• W4313706516 hasIssue "1" @default.
• W4313706516 hasLocation W43137065161 @default.
• W4313706516 hasLocation W43137065162 @default.
• W4313706516 hasLocation W43137065163 @default.
• W4313706516 hasLocation W43137065164 @default.
• W4313706516 hasLocation W43137065165 @default.
• W4313706516 hasLocation W43137065166 @default.
• W4313706516 hasOpenAccess W4313706516 @default.
• W4313706516 hasPrimaryLocation W43137065161 @default.
• W4313706516 hasRelatedWork W2089799952 @default.
• W4313706516 hasRelatedWork W2132925182 @default.
• W4313706516 hasRelatedWork W2409609380 @default.
• W4313706516 hasRelatedWork W2748952813 @default.
• W4313706516 hasRelatedWork W2899084033 @default.
• W4313706516 hasRelatedWork W2947323098 @default.

• next